| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
American Medical Technologies is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Healthcare organizations and technology vendors connect to Redox once, then authorize what data they send to and receive from partners through a centralized hub. Redox`s cloud-based platform is vendor and standards agnostic and enables the secure and efficient exchange of healthcare data. This approach eradicates the need for point-to-point integrations and accelerates the discovery, adoption, and distribution of patient and provider-facing technology solutions. With hundreds of healthcare organizations and technology vendors exchanging data today, Redox represents the largest interoperable network in healthcare.
Palo Alto Research Center is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Out-of-pocket healthcare expenses are on the rise, which means patients are having difficulty paying their share and providers are finding it difficult to collect from those patients. It`s a lose-lose situation. CarePayment offers a unique solution that helps patients meet their financial obligations and protect their financial health while helping providers stay financially healthy by reducing bad debt and improving cash flow.